ClinicalTrials.gg
RecruitingNCT07707102ASCENTUpdated Nov 5, 2026

Advancing Skills Through Consultation, Education, and Novel Technologies

An interventional study of Live workshop and AI-enhanced Web-based training in PTSD - Post Traumatic Stress Disorder, sponsored by The University of Texas Health Science Center at San Antonio. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by The University of Texas Health Science Center at San Antonio · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Nov 5, 2026Eligibility revisedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Sex
All
01

Study summary

This research study tests strategies to train behavioral health providers in Written Exposure Therapy (WET), an evidence-based treatment for posttraumatic stress disorder (PTSD). There are a number of evidence-based treatments for posttraumatic stress disorder (PTSD). However, most behavioral health providers have not received training in these PTSD treatments and do not offer them regularly to their patients.

The researchers hope to learn about the optimal way to train behavioral providers in this type of treatment. This study is designed to determine the comparative effectiveness of different training strategies on key outcomes such as how much competency providers develop in the therapy and to how many patients they deliver the therapy. This study will help the researchers understand if we can help more providers learn to competently delivery Written Exposure Therapy by using strategies that are more convenient and cost less money, including web-based and AI-facilitated training supports. This study will also help us learn which training strategies work best for which providers so that in the future we can make personalized training recommendations.

Read the detailed description

This study will enroll behavioral health providers (i.e., professional therapists) and test a training program for Written Exposure Therapy that includes

  1. an enhanced, web-based foundational training (web-based training plus integrated TherapyTrainer components) and
  2. an AI training support tool for competency development (TherapyTrainer).

This randomized clinical trial will compare web/AI training, among providers who serve Veterans and Service Members, to standard Written Exposure Therapy training (i.e., human-delivered live workshop and consultation calls) on provider, patient, and cost-effectiveness outcomes. There is no cross-over of conditions. Providers in both conditions will be eligible to earn continuing education credits and approval as Written Exposure Therapy Providers who have completed competency based training and two training cases.

02

Conditions studied

  • PTSD - Post Traumatic Stress Disorder

Browse trials for

Keywords

  • Written Exposure Therapy
  • AI-facilitated training
03

In context

Combat Disorders

200 studies on the registry are indexed under Combat Disorders; 90 are open to participants now.

This study's planned enrollment of 300 is above the median of 72 across 167 interventional studies indexed under Combat Disorders.

Browse Combat Disorders studies →

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 445 studies on the registry; 89 are open to participants now.

Of its 65 completed or terminated interventional studies of FDA-regulated products, 35 (54%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 5, 2026. See what changed

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. mental health provider;
  2. serves U.S. veterans and/or U.S. service members with PTSD;
  3. willing to participate in either live or web-based training.

Exclusion criteria

Exclusion Criteria:

1. has already completed formal training in Written Exposure Therapy

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    Workshop + Consultation Calls

    10-hour, live workshop over 2 days with a live trainer via video conferencing. There will also be twelve 1 hour calls with a live therapy consultant .

    Behavioral: Live workshop · Behavioral: Consultation video calls

  • Active comparator
    Workshop + TherapyTrainer

    10-hour, live workshop over 2 days with a live trainer via video conferencing.There will also be approximately 12 hours of engagement with the AI training support tool (TherapyTrainer)

    Behavioral: Live workshop · Behavioral: TherapyTrainer

  • Active comparator
    Web-Based Training + Consultation Calls

    AI enhanced Web-based training with no live meetings, but approximately 8-10 hours of asynchronous, self-paced training. There will also be twelve 1 hour calls with a live therapy consultant .

    Behavioral: AI-enhanced Web-based training · Behavioral: Consultation video calls

  • Active comparator
    Web-based Training + TherapyTrainer

    AI enhanced Web-based training with no live meetings, but approximately 8-10 hours of asynchronous, self-paced training. There will also be approximately 12 hours of engagement with the AI training support tool (TherapyTrainer)

    Behavioral: AI-enhanced Web-based training · Behavioral: TherapyTrainer

Interventions

  • BehavioralLive workshop

    Approximately 10 hours (excluding breaks) over 2 days with a live trainer via video conferencing (e.g., Zoom)

  • BehavioralAI-enhanced Web-based training

    No live meetings, but approximately 8-10 hours of asynchronous training at the learner's pace over about 1 month.

  • BehavioralConsultation video calls

    Twelve 1-hour calls with a live therapy consultant via videoconferencing (e.g., Zoom)

  • BehavioralTherapyTrainer

    No live meetings, but approximately 12 hours of engaging with the AI training support tool (TherapyTrainer)

    Also known as: AI Training Tool

06

What researchers measure

Primary outcomes

  1. Provider WET Competency

    A 20-item multiple choice treatment knowledge assessment. Higher scores indicate greater knowledge of WET.

    Time frame: Baseline to 7 months

Secondary outcomes

  1. Completion of Practice Cases

    Number of participants that complete practice cases

    Time frame: 4 months

  2. Time to complete Practice Cases

    Number of days to complete two training cases (real or simulated)

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The PI will ensure all mechanisms used to share data will include proper plans and safeguards for the protection of privacy, confidentiality, and security for data dissemination and reuse (e.g., all data will be de-identified and will not be traceable to a specific study participant).

Supporting information: Study protocol, Statistical analysis plan

Time frame: At study completion and after data analysis is complete

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Aug 2028, 24 months after the start.

Of 73 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 24 months is close to that.

Counting every sponsor, half of 79 studies reached it within 25 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2026
First posted
Jul 16, 2026
StartActual
Aug 20, 2026
Primary completionEst.
Aug 31, 2028
CompletionEst.
Aug 31, 2028
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • Editedserves U.S. veterans and/or U.S. service members with PTSD (by self-report);
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • Editedserves U.S. veterans and/or U.S. service members with PTSD (by self-report);

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07707102
Responsible party
Stefanie LoSavio (Assistant Professor, The University of Texas Health Science Center at San Antonio) — Principal investigator
First posted
Jul 16, 2026
Start date
Aug 20, 2026
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Nov 5, 2026

Study contacts

Stefanie Losavio, PhD
Contact
ASCENT@uthscsa.edu
(210) 562-6714
Stefanie LoSavio, PhD
principal investigator · The University of Texas Health Science Center at San Antonio

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion